Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
Abbott Enhances Heart Failure Care with Aspirin-Free Regimen for HeartMate 3™ Patients
ABBOTT PARK, Ill.— Abbott recently announced that the U.S. Food and Drug…
FDA Grants Accelerated Approval to Gilead’s Livdelzi for PBC
FOSTER CITY, Calif : Gilead Sciences recently announced that the U.S. Food…
Novartis’ Fabhalta gets FDA nod for IgAN Treatment
Basel- August 2024- Novartis announced that the U.S. Food and Drug Administration…
Is This the Future of Afib Treatment? Mayo Clinic’s Answer
Rochester- July 2024- Cardiologists in Mayo Clinic's Heart Rhythm Clinic are using…
Tempus’ xT CDx Achieves Breakthrough Designation as First ADLT for Tumor Mutation Profiling
July 2024- Tempus announced that the Centers for Medicare & Medicaid Services…
Good News! Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a)
Basel- 22 May 2024 - Roche announced that the Tina-quant® lipoprotein Lp(a)…
Lilly Statement on FDA Advisory Committee Meeting on Donanemab
May 2024- The U.S. Food and Drug Administration (FDA) will convene an…
Latest CAVT Technology Designed to Remove Blood Clots
April 2024- Penumbra announced the U.S. Food and Drug Administration (FDA) clearance…
Abbott’s Breakthrough Dissolving Stent Receives FDA Approval
May 2024- Abbott announced that the U.S. Food and Drug Administration (FDA)…